EMEA-000174-PIP01-07-M03

  • Email
  • Help

Overview

Product details for Mozobil
Invented nameMozobil
Active substance

Plerixafor

Decision numberP/0253/2013
PIP numberEMEA-000174-PIP01-07-M03
Pharmaceutical form(s)Solution for injection
Condition(s)/indication(s)

Myelosuppression caused by chemotherapy to treat malignant disorders, which requires an autologous haematopoietic stem cell transplant

Route(s) of administrationSubcutaneous use, Intravenous use
PIP applicant

Genzyme Europe B.V.
The Netherlands
E-mail: eumedinfo@genzyme.com
Tel. +31 3569 98685
Fax +31 3569 48756

Decision typePM: decision on the application for modification of an agreed PIP

Decision